DBVT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DBV Technologies SA (DBVT) does not present a strong buy opportunity at this time for a beginner investor with a long-term focus. While the company has shown improvement in its financials and has potential catalysts like the upcoming BLA submission for Viaskin Peanut, the stock's recent price decline, lack of strong technical signals, and mixed analyst ratings suggest a cautious approach. Holding the stock or waiting for more favorable conditions would be more prudent.
The MACD is positive but contracting, indicating weakening bullish momentum. RSI is neutral at 43.835, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near its support level (S1: 20.055), and recent price action shows a decline of -3.01% in the regular market and -2.54% in pre-market trading. This suggests a lack of immediate upward momentum.
Revenue increased by 26.22% YoY in Q4
Net income improved significantly, up 94.78% YoY.
Upcoming BLA submission for Viaskin Peanut in 1H26, with potential approval next year.
Recent price target downgrade by Goldman Sachs to EUR 1.01 with a Sell rating.
Lack of recent news or significant trading trends.
Stock price has declined in recent sessions, showing weak sentiment.
In Q4 2025, revenue grew by 26.22% YoY to $645,000. Net income improved significantly, reducing losses by 94.78% YoY to -$44.83M. EPS improved to -0.24, up 4.35% YoY. Gross margin remained stable at 100%.
Mixed ratings: Goldman Sachs downgraded the stock with a Sell rating and a price target of EUR 1.01. Citizens raised the price target to $47 with an Outperform rating, citing confidence in the BLA submission and potential approval of Viaskin Peanut.
